Evidence map›Paper›PMID 35609996›Full record

ArticleJournal of the American Society of Nephrology : JASN2022

Effects of Short-Term Potassium Chloride Supplementation in Patients with CKD.

Martin Gritter, Rosa D Wouda, Stanley M H Yeung, Michiel L A Wieërs, Frank Geurts, Maria A J de Ridder, Christian R B Ramakers, Liffert Vogt, Martin H de Borst, Joris I Rotmans and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07494266 (Säkerheten av en hälsosam växtbaserad Kost Med högre kaliuminnerhåll, jämfört Med en hälsosam växtbaserad Kost Med begränsat kaliuminnehåll Hos Patienter Med Kronisk Njursjukdom), which is not on this map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07494266 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Säkerheten av en hälsosam växtbaserad Kost Med högre kaliuminnerhåll, jämfört Med en hälsosam växtbaserad Kost Med begränsat kaliuminnehåll Hos Patienter Med Kronisk Njursjukdom: En Pilotstudie

TypeinterventionalSponsorKarolinska InstitutetRan2026 to 2030Enrolled30ConditionsHyperkalemia, Chronic Kidney Disease (Stages 4 and 5)ArmsHealthy plant-based diet (healthy-PBD), Potassium-restricted plant-based diet
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 60 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Potassium and the kidney.Nature reviews. Nephrology · 2026
    Review
  5. Review
  6. ASN Kidney Health Guidance on Potassium and Phosphorus Food Additives.Journal of the American Society of Nephrology : JASN · 2025
    Article
  7. Estimated potassium intake and the progression of chronic kidney disease.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2024
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Hypertension in chronic kidney disease-treatment standard 2023.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Martin GritterDepartment of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands.
Rosa D WoudaDivision of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Stanley M H YeungDivision of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.
Michiel L A WieërsDepartment of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands.
Frank GeurtsDepartment of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands.
Maria A J de RidderDepartment of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands.
Christian R B RamakersDepartment of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.
Liffert VogtDivision of Nephrology, Amsterdam University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0002-4585-7505
Martin H de BorstDivision of Nephrology, University Medical Center Groningen, Groningen, The Netherlands.ORCID 0000-0002-4127-8733
Joris I RotmansDepartment of Internal Medicine, Division of Nephrology, Leiden University Medical Center, Leiden, The Netherlands.ORCID 0000-0001-9682-6234
Ewout J HoornDepartment of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, Rotterdam, The Netherlands.ORCID 0000-0002-8738-3571
on behalf of K onsortium
Erasmus MC · NLAmsterdam University Medical Centers · NLUniversity Medical Center Groningen · NLLeiden University Medical Center · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundObservational studies suggest that adequate dietary potassium intake (90-120 mmol/day) may be renoprotective, but the effects of increasing dietary potassium and the risk of hyperkalemia are unknown.

methodsThis is a prespecified analysis of the run-in phase of a clinical trial in which 191 patients (age 68±11 years, 74% males, 86% European ancestry, eGFR 31±9 ml/min per 1.73 m

resultsKCl supplementation significantly increased urinary potassium excretion (72±24 to 107±29 mmol/day), plasma potassium (4.3±0.5 to 4.7±0.6 mmol/L), and plasma aldosterone (281 [198-431] to 351 [241-494] ng/L), but had no significant effect on urinary sodium excretion, plasma renin, BP, eGFR, or albuminuria. Furthermore, KCl supplementation increased plasma chloride (104±3 to 105±4 mmol/L) and reduced plasma bicarbonate (24.5±3.4 to 23.7±3.5 mmol/L) and urine pH (all

conclusionsIn patients with CKD stage G3b-4, increasing dietary potassium intake to recommended levels with potassium chloride supplementation raises plasma potassium by 0.4 mmol/L. This may result in hyperkalemia in older patients or those with higher baseline plasma potassium. Longer-term studies should address whether cardiorenal protection outweighs the risk of hyperkalemia.

Indexed as

HyperkalemiaRenal Insufficiency, ChronicAgedDietary SupplementsFemaleHumansMaleMiddle AgedPotassiumPotassium ChloridePotassium, DietaryPotassiumPotassium ChloridePotassium, Dietaryacidosisaldosteronechronic kidney diseaseclinical trialdietary supplementselectrolyteshypertensionpotassium chloride

Identifiers

PMID35609996
PMCPMC9529195
OpenAlexW4282943573

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.